EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
Update on assessment of the BioNTech and Pfizer BNT162b2 vaccine marketing authorisation application
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA takes key action in fight against COVID-19 by issuing Emergency Use Authorization for first COVID-19 vaccine
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine
- Details
- Category: EMA
![EMA EMA](/images/logo/ema.png)
FDA authorizes monoclonal antibodies for treatment of COVID-19
- Details
- Category: FDA
![FDA FDA](/images/logo/fda.png)
More Pharma News ...
- FDA approves first treatment for COVID-19
- EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation
- FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment
- FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
- FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Global regulators commit to cooperate on observational research in the context of COVID-19